Exhibit 10.1





Exhibit 10.1




[TO BE INSERTED ON RELEVANT BROKER’S LETTERHEAD]




Private and Confidential




[insert date] November 2010




	 	 	 
	[name]

	 	URGENT
	[company]
	 	 
	[address]

	 	FAX CONFIRMATION REQUIRED TO BE
	[address]

	 	RECEIVED BY YOUR BROKER BY
	 

	 	4.00PM (AEDT)
	Email: [insert details]

	 	26 November 2010






Dear [insert name]




UNILIFE CORPORATION — PLACEMENT OFFERS & ALLOCATION FOR AUSTRALIAN RESIDENTS




We act as a placement agent for Unilife Corporation (Unilife).



Unilife is pleased to invite you to subscribe for CHESS Depositary Interests (CDIs) (each
representing an interest in one-sixth of a share of common stock) and free unlisted attaching
options in Unilife under a placement to raise up to approximately A$33.9 million (Placement) on the
terms set out in this letter (Subscription Agreement). Details of the CDIs and free unlisted
attaching options in Unilife for which you are invited to subscribe are set out in Section 2.



Unilife also proposes to offer additional CDIs to its existing Australian and New Zealand resident
shareholders at the Placement Price under a Share Purchase Plan to raise up to approximately A$7
million. Unilife reserves the right to accept applications for such higher amount as the Company,
in its absolute discretion, determines subject to the maximum number of CDIs which Unilife is
permitted to issue under the NASDAQ Listing Rules without shareholder approval (ie, not more than
20% of the issued capital of Unilife when aggregated with the CDIs issued under the Placement). For
this purpose, investors should be aware that the calculation of the 20% limit under the NASDAQ
Listing Rules is determined differently to the calculation of Unilife’s 15% issue capacity under
the ASX Listing Rules.




	1.	 	Summary of the Placement






The following are the principal terms of the Placement and defined terms used in this Subscription
Agreement:



	 	 	 
	Company or Unilife

	 	Unilife Corporation (ARBN 141 042 057)
	 
	 	 
	Placement

	 	The proposed issue by the Company of (i) the
Placement CDIs at the Placement Price and (ii) the
Placement Options to sophisticated and professional
investors in Australia.
	 
	 	 
	Amount of Placement

	 	Up to A$33.9 million.
	 
	 	 
	 

	 	The Company reserves the right to accept any lesser
amount raised under the Placement at its absolute
discretion.
	 
	 	 
	 

	 	To the extent that the Company receives applications
for in excess of A$28.3 million, the issue of the
Tranche 2 Placement Options will be subject to
Shareholder Approval as described below.
	 
	 	 
	Option Agreement

	 	The Option Agreement setting out the terms on which
the Placement Options will be granted in the form
annexed to this Subscription Agreement.





 


 









 







			
	Subscription Agreement for Unilife Placement
	 	Page 2






	 	 	 
	Placement CDIs

	 	Up to 39,986,592 CDIs in the Company (each
representing an interest in one-sixth of a share of
common stock) to be issued under the Placement at the
Placement Price.
	 
	 	 
	 

	 	Placement CDIs will be quoted on ASX and the
Company’s shares of common stock are quoted on
NASDAQ.
	 
	 	 
	 

	 	Subject to ASX approval, all CDIs in the Company
(including CDIs which may be issued upon conversion
of the Underlying Shares) will be subject to a FOR US
restriction which will prevent resale of such CDIs
into the US without a registration statement or an
available exemption from registration. In addition,
the Underlying Shares may not be resold in the US
without registration or an available exemption from
registration.
	 
	 	 
	Placement Price

	 	A$0.85 per CDI (equivalent to A$5.10 per share of
common stock in the Company).
	 
	 	 
	Placement Options

	 	For every 24 Placement CDIs allotted, investors will
be issued for nil cash consideration, two free
unlisted options (a Tranche 1 option and a Tranche 2
option) in the Company. Fractional entitlements to
Placement Options will be rounded down to the nearest
whole number of Placement Options.
	 
	 	 
	 

	 	Each option will entitle the investor to subscribe
for one fully paid share of common stock in the
Company. Investors may elect to receive the
Underlying Shares issued on exercise of the Placement
Options in the form of common stock or CDIs (with
each CDI representing an interest in one-sixth of a
share of common stock).
	 
	 	 
	 

	 	The options will be issued with an exercise price per
share of common stock of: Tranche 1 — A$7.50
(equivalent to A$1.25 per CDI), Tranche 2 A$12.00
(equivalent to A$2.00 per CDI) on the terms and
conditions set out in the Option Agreement.
	 
	 	 
	 

	 	In the event that the Company receives applications
under the Placement for in excess of A$28.3 million,
the issue of the Tranche 2 options will be subject to
the Company obtaining Shareholder Approval for their
issue.
	 
	 	 
	Shareholder Approval

	 	The issue of the Tranche 2 Placement Options will, in
the event that Unilife receives applications under
the Placement in excess of A$28.3 million, be
conditional upon approval being obtained from
shareholders of Unilife for their issue in accordance
with ASX Listing Rule 7.1 at an extraordinary meeting
of shareholders of the Company which is scheduled to
occur in late January 2011.
	 
	 	 
	 

	 	Unilife does not warrant that shareholder approval
(if required) will be obtained for the issue of the
Tranche 2 Placement Options.
	 
	 	 
	Underlying Shares

	 	The shares of common stock in Unilife Corporation
issued to investors on exercise of the Placement
Options.
	 
	 	 
	Use of Proceeds

	 	Unilife intends to use the proceeds raised from the
Placement for the purchase of capital equipment, for
general operations and to cover the costs of the
Placement.
	 
	 	 
	 

	 	Notwithstanding the above, the Unilife reserves the
right to change the use of proceeds in its sole
discretion, from time to time.





 


 









 






			
	Subscription Agreement for Unilife Placement
	 	Page 3






	2.	 	Your allocation






Unilife is pleased to confirm that you, as the addressee of this Subscription Agreement (you), are
invited to subscribe for the number of Placement CDIs and Placement Options set out below.



	 	 	 	 	 	 	 
	 	 	Subscription	 	DVP settlement funds	 	If not settling via DVP -
	Number of securities	 	amount (A$)	 	required by	 	funds required by
	[insert amount]

Placement CDIs


[insert amount]

Placement 
Options*

	 	A$[insert amount]
	 	5:00pm, Thursday 2

December 2010

(Australian Eastern

Daylight Time)
	 	If paying by cheque -

5.00pm on Monday 29

November (Australian

Eastern Daylight Time)


If paying by electronic

funds transfer - 5.00pm,

on Tuesday 30
 November
2010
 (Australian Eastern

Daylight Time)








	 	 	 
	*	 	Investors will receive two Placement Options (a Tranche 1 option and a Tranche 2 option) for
every 24 Placement CDIs which they subscribe for under the Placement.





This offer is made to you on the terms and conditions set out in this Subscription Agreement. The
term “you” in this letter shall include any person or entity which applies for or is allotted
Placement CDIs and/or Placement Options on your behalf, including as nominee or custodian.



By returning the completed Placement Application Form (attached to this Subscription Agreement)
including the making of your investor representations in this Subscription Agreement and the Option
Agreement, you are irrevocably applying for the allotment and issue to you of the number of
Placement CDIs and Placement Options set out above on the terms set out in this Subscription
Agreement and the Option Agreement without the need for any separate instrument of application.



Upon receipt of the completed Placement Application Form together with payment of the above
Subscription Amount in cleared funds the Company agrees to allot and issue to you the number of
Placement CDIs and Placement Options set out above.



Upon the allotment of Placement CDIs and Placement Options to you, you agree to:




	(a)	 	accept the Placement CDIs and Placement Options issued to you on the terms of the offer as
set out in this Subscription Agreement;

	 
	(b)	 	be bound by the Company’s certificate of incorporation and by-laws; and







	(c)	 	authorise your name to be placed on the register of members of the Company as the legal owner
of the Placement CDIs and on the Company’s option register as the legal owner of the Placement
Options issued to you.






Pursuant to the terms of the Placement Application Form and this Subscription Agreement, you
acknowledge that the Placement CDIs, Placement Options and the Underlying Shares have been offered
and will be sold to you, in compliance with Regulation S of the United States Securities Act of
1933, as amended (the US Securities Act) and, as a result, the Placement CDIs, the Placement
Options and the Underlying Shares will constitute “restricted securities” as such term is defined
under Rule 144 of the US Securities Act. In light of the restricted nature of the Placement CDIs,
the Placement Options and the Underlying Shares, you covenant and agree (i) not to sell the
Placement CDIs, the Placement Options or the Underlying Shares except as permitted under the US
Securities
Act pursuant to registration or to an exemption from registration, and (ii) not to engage in
hedging transactions involving the Placement CDIs, the Placement Options or the Underlying Shares
unless in compliance with the US Securities Act. You also covenant and agree that you will not
exercise the Placement Options unless at the time of exercise (i) you are outside the United States
and (ii) you are not a US person, as defined in Regulation S (and will not be acquiring the
Underlying Shares on behalf of or for the account of or benefit of, a US person).


 


 









 






			
	Subscription Agreement for Unilife Placement
	 	Page 4






	3.	 	Timetable






The proposed timetable for the Placement is as follows:



	 	 	 	 	 
	Action	 	Time*	 
	Return of Placement Application Form to Brokers
	 	by 4.00pm on 26 November 2010	 
	Payment of subscription amount (if paying subscription amount by cheque)**
	 	by 5.00 pm on 29 November 2010	 
	Payment of subscription amount (if paying subscription amount by EFT)
	 	by 5.00pm on 30 November 2010	 
	Settlement via DVP
	 	2 December 2010	 
	Allotment of Placement CDIs
	 	3 December 2010	 
	Allotment of Placement Options (not subject to shareholder approval being obtained)
	 	10 December 2010***	 
	Unilife Extraordinary Meeting of shareholders to consider resolution to approve the issue of the Tranche 2 Placement Options (if required)
	 	late January 2011	 
	Allotment of Tranche 2 Placement Options (if Shareholder Approval is required to be obtained for their allotment)
	 	within 3 business days after the Extraordinary Meeting****	 








	 	 	 
	*	 	All times above are references to Australian Eastern Daylight time.

	 
	**	 	Settlement via DVP or by electronic funds transfer is preferred to settlement by cheque.

	 
	***	 	Delay in timing of allotment is necessary to effect the preparation and delivery of option
certificates.

	 
	****	 	Assuming shareholder approval is obtained at the Extraordinary Meeting





Quotation of the CDIs on ASX will occur following allotment of the relevant Placement CDIs. The
Company will not apply for listing of the Placement Options on ASX, NASDAQ or any other exchange.



Please note that the above timetable may change without consultation with you and you are bound by
your Subscription Agreement, notwithstanding any such changes to the timetable.



The Company reserves the right not to proceed with the Placement or any part of it at any time
before the allotment of Placement CDIs and Placement Options to you. If the Placement or any part
of it does not proceed or is cancelled, all relevant Subscription Amounts relating to the cancelled
part of the Placement will be refunded (without interest).




	4.	 	Rights and restrictions attaching to the Placement CDIs, the Placement Options and the
Underlying Shares






The Placement CDIs will rank pari passu in all respects with the CDIs of Unilife on issue as at the
date of their allotment. The Placement CDIs are being offered pursuant to the Regulation S
exemption from registration under the US Securities Act, and as such, cannot be offered or sold to
“US persons” (as defined under Regulation S of the US Securities Act).


 


 









 






			
	Subscription Agreement for Unilife Placement
	 	Page 5





Subject to ASX approval, all CDIs in the Company will be subject to a FOR US restriction which will
prevent resale of such CDIs into the US without a registration statement or an available exemption
from registration.



Investors should be aware that restrictions will be imposed on the ability of an investor to
convert the Placement CDIs into shares of common stock in Unilife until a registration statement
has been filed with the SEC.



The Placement Options will be options to acquire common stock in Unilife and will be issued on the
terms set out in the Option Agreement. The Placement Options will not be listed on ASX, NASDAQ or
any other exchange. Investors should be aware that the Underlying Shares will bear a legend
stating that transfers of the shares will be prohibited except in accordance with Regulation S,
pursuant to a registration statement or pursuant to an available exemption from registration and
that hedging transactions involving the Placement Options and the Underlying Shares may not be
conducted unless in compliance with the US Securities Act.



Investors should further be aware that allotment of the Tranche 2 Placement Options may be subject
to Shareholder Approval as described in Section 1 above.



Upon allotment, Unilife will apply for official quotation of the Placement CDIs on ASX. Please
note that ASX Participating Organisations (as defined in the ASX Business Rules) cannot deal in the
Placement CDIs either as principal or agent until official quotation is granted in respect of the
CDIs. The Placement Options and the Underlying Shares are being or will be offered pursuant to the
Regulation S exemption from registration under the US Securities Act and as such cannot be offered
or sold to ‘US’ persons as defined under Regulation S of the US Securities Act.




	5.	 	Issue of Placement CDIs and Placement Options






Placement CDIs — DVP settlement




Subject to the Company receiving payment in full for your Subscription Amount, the Placement CDIs
will be issued on a DVP basis on 3 December 2010.



Placement CDIs — Non-DVP settlement




Subject to the Company receiving payment in full in cleared funds for the Subscription Amount, the
Placement CDIs will be issued on 3 December 2010.



Placement Options




The Placement Options (excluding any Tranche 2 Placement Options which are subject to Shareholder
Approval) will, subject to the Company receiving payment in full for your Subscription Amount, be
issued on 10 December 2010.



In the event that Shareholder Approval is required for the allotment of the Tranche 2 Placement
Options, allotment of the Tranche 2 Placement Options will occur (subject to Shareholder Approval
for their issue being obtained which is expected to take place in late January 2011) within 3
business days after the Extraordinary Meeting approving their allotment.




	6.	 	Offer personal






The invitation for you to subscribe for Placement CDIs and Placement Options on the terms and
conditions set out in this Subscription Agreement is personal to you. You may not, prior to
allotment of the Placement CDIs and Placement Options, assign, transfer or deal in any other
manner, with Placement CDIs and Placement Options, or your rights or obligations under this
Subscription Agreement without the prior written agreement of Unilife.


 


 









 







			
	Subscription Agreement for Unilife Placement
	 	Page 6






	7.	 	Representations, warranties and agreements






By accepting this invitation (by returning the completed Placement Application Form) you represent,
warrant and agree for the benefit of Unilife and its related bodies corporate and any officers,
employees, agents, advisers or brokers of any of them (affiliates) that:




	(a)	 	You are:







	 	(i)	 	a “Sophisticated Investor” under section 708(8) of the Corporations Act 2001
(Cth) (Corporations Act); or







	 	(ii)	 	a “Professional Investor” under section 708(11) of the Corporations Act.







	(b)	 	You confirm that you are in compliance with all relevant laws and regulations and will not
cease to be in compliance if you apply for Placement CDIs and Placement Options on the terms
set out in this Subscription Agreement.







	(c)	 	In accepting this offer to apply for Placement CDIs and Placement Options on the terms set
out in this Subscription Agreement you are not subscribing for Placement CDIs and Placement
Options for the purpose of selling or transferring the Placement CDIs and Placement Options
issued to you or granting, issuing or transferring interests in, or options over the Placement
CDIs and Placement Options within 12 months of their date of issue. This confirmation is
understood to be a statement by you of present intention only but not an undertaking not to
sell, particularly where your investment objectives or market conditions change.







	(d)	 	You acknowledge that no disclosure document has been prepared under the Corporations Act in
connection with the offer of the Placement CDIs or the Placement Options.







	(e)	 	You have such knowledge and experience in financial and business matters that you are capable
of evaluating the merits and risks of a subscription for Placement CDIs and Placement Options
and you acknowledge that an investment in Placement CDIs and Placement Options involves a
degree of risk.







	(f)	 	You have the financial ability to bear the economic risk of an investment in the Placement
CDIs and Placement Options.







	(g)	 	You are aware that publicly available information about Unilife can be obtained from ASX
(including its web site http://www.asx.com.au), the SEC (including its website
http://www.sec.gov) and that certain publicly available information about Unilife can be
obtained free of charge from Unilife’s web site: www.unilife.com.







	(h)	 	You have had access to all information that you believe is necessary or appropriate in
connection with your application for Placement CDIs and Placement Options. You acknowledge and
agree that you will not hold Unilife or its affiliates or any of their respective officers,
employees, agents, advisers or affiliates responsible for any misstatements in, or omissions
from, any publicly available information concerning Unilife.







	(i)	 	You have made and relied upon your own assessment of Unilife and have conducted your own
investigation with respect to the Placement CDIs and Placement Options and Unilife including,
without limitation, the particular tax consequences of subscribing, owning or disposing of
Placement CDIs and Placement Options in light of your particular situation as well as any
consequences arising under the laws of any other taxing jurisdiction.







	(j)	 	You have not relied on any representations made by Unilife, its affiliates or any of their
respective officers, employees, agents, advisers or affiliates except as set out in this
Subscription Agreement.







	(k)	 	You have not relied on any investigation that Unilife, its affiliates or any of their
respective officers, employees, agents, advisers or affiliates or any persons acting on their
behalf may have conducted with respect to the Placement CDIs and the Placement Options or
Unilife. None of such persons has made any representation to you, express or implied, with
respect to the Placement CDIs and the Placement Options or Unilife.




 


 









 






			
	Subscription Agreement for Unilife Placement
	 	Page 7






	(l)	 	You acknowledge that this Subscription Agreement does not constitute a securities
recommendation or financial product advice and that Unilife or its affiliates have not
considered your particular objectives, financial situation and needs.







	(m)	 	You agree to be bound by the provisions of the certificate of incorporation and by-laws of
Unilife upon allotment of Placement CDIs to you and the issue of the Underlying Shares on
exercise of the Placement Options held by you.







	(n)	 	Except to the extent that liability cannot be excluded by law, you acknowledge that none of,
Unilife or its affiliates or any of their respective related bodies corporate, officers,
employees, agents, advisers or affiliates, accept any responsibility in relation to the
Placement.







	(o)	 	You are not a Related Party (as defined in the ASX Listing Rules) of Unilife.







	(p)	 	You acknowledge and agree that, in order to ensure that US Persons do not purchase any
Placement CDIs or the Underlying Shares issued to you, a number of procedures governing the
trading and clearing of CDIs will be implemented, including the application to CDIs of the
status of Foreign Ownership Restriction (FOR) securities under the ASX Settlement Operating
Rules and the addition of the notation “FORUS” to the CDI description on ASX trading screens
and elsewhere, which will inform the market of the prohibition on US Persons acquiring CDIs.







	(q)	 	You understand and agree that the offer and sale to you of the Placement CDIs, the Placement
Options and the Underlying Shares has not been and will not be registered under the US
Securities Act or the laws of any state or other jurisdiction in the United States but rather
the issue of the Placement CDIs and the Placement Options under this Subscription Agreement
and the issue of the Underlying Shares on exercise of the Placement Options will be made in
reliance on an exemption from registration contained in Regulation S under the US Securities
Act for offers and sales made outside of the US. Therefore, you agree that (i) you may not
and will not offer, sell, pledge, transfer or otherwise dispose of any Placement CDIs, any
Placement Options or any Underlying Securities in the United States or for the account or
benefit of a U.S. person (as defined in Regulation S of the US Securities Act) (US Person)
unless and until the Placement CDIs, the Placement Options or the Underlying Shares (as
applicable) are registered under the US Securities Act (which you acknowledge Unilife has no
obligation to do) or offered, sold, pledged, transferred or otherwise disposed of in a
transaction exempt from, or not subject to, the registration requirements of the US Securities
Act or the laws of any state or other jurisdiction in the United States; and (ii) you may not
engage in hedging transactions involving the Placement CDIs, the Placement Options or the
Underlying Shares unless in compliance with the US Securities Act. You further acknowledge
that (i) each Placement Option certificate will bear a legend stating that it and the
Underlying Shares have not been registered under the US Securities Act and that such option
may not be exercised by or on behalf of any US person unless registered under the US
Securities Act or an exemption from registration is available, and no hedging transactions
involving the Placement Options or the Underlying Shares may be conducted unless in compliance
with the US Securities Act, and (ii) upon exercise of such option, you will be required to
give a written certification that you are outside the US and that you are not a US person and
that the Placement Option is not being exercised on behalf of a US person.







	(r)	 	You represent that (i) at the time that you submit your Placement Application Form to the
Company, (ii) at the time of allotment of the Placement CDIs and the Placement Options, and
(iii) at the time of exercise of the Placement Options, you are and will be (i) outside the
United States and (ii) not a US person, as defined in Regulation S and are not and will not be
acquiring the Placement CDIs, the Placement Options or the Underlying Shares on behalf of or
for the account of or benefit of, a US person.




 


 









 






			
	Subscription Agreement for Unilife Placement
	 	Page 8






	(s)	 	You have full corporate power and lawful authority to execute and deliver this Subscription
Agreement and to perform, or cause to be performed, your obligations under this Subscription
Agreement.







	(t)	 	This Subscription Agreement constitutes a legal, valid and binding obligation on you,
enforceable in accordance with its terms.







	(u)	 	If you are acquiring any Placement CDIs and Placement Options for an account of one or more
persons, you have full power to make the foregoing acknowledgments, representations,
warranties and agreements on behalf of each such person and you will take reasonable steps to
ensure that each such person will comply with its obligations herein.







	(v)	 	You acknowledge that Unilife and its affiliates will rely upon the truth and accuracy of the
foregoing acknowledgments, representations, warranties and agreements and agree that if any
such acknowledgments, representations or warranties are no longer accurate, you will notify
Unilife immediately. You indemnify Unilife, its affiliates and their respective officers,
employees, advisers and affiliates against any loss, damage or costs incurred and arising out
of or in relation to any breach by you of the acknowledgments, representations, warranties and
agreements.







	(w)	 	You acknowledge that if you have material non-public information regarding the Company
insider trading restrictions may apply to you. You agree not to, and not to cause any other
person to, trade any of the Company’s securities after you have had access to material
non-public information if doing so would be a breach of insider trading restrictions.







	8.	 	Confidentiality






You must not disclose the contents of this Subscription Agreement, any transactions contemplated by
this Subscription Agreement or any information provided to you with respect to the Company or the
Placement without the prior written consent of the Company, except to the extent that the
disclosure is required by law.




	9.	 	Announcements






You may not make any public announcement or communication concerning the transactions referred to
in this Subscription Agreement without obtaining the prior written consent of Unilife except as
required by law or a regulation of a stock exchange.




	10.	 	Governing law and jurisdiction






This Subscription Agreement between us arising out of your acceptance of the terms of this
invitation to apply for Placement CDIs and Placement Options shall be governed by the laws of New
South Wales, Australia and you agree to submit to the exclusive jurisdiction of the courts of that
State.




	11.	 	Entire agreement






The terms contained in this Subscription Agreement including, without limitation, the Option
Agreement and your executed Placement Application Form, constitute the entire agreement among you
and Unilife and your participation in the Placement to the exclusion of all prior representations,
understandings and agreements among you and Unilife. Any variation of the terms of this
Subscription Agreement must be in writing signed by Unilife and you.




	12.	 	Notices






Any notice to be given relating to the offer of Placement CDIs and Placement Options or this
Subscription Agreement may be sent by mail or by facsimile to the facsimile number of the party to
whom the notice is sent and will be deemed to have been given one business day after being mailed
or upon the successful transmission to that facsimile number.


 


 









 






			
	Subscription Agreement for Unilife Placement
	 	Page 9






	13.	 	Commission






The Company has agreed to pay to the brokers in connection with the Placement a cash payment of 5%
of the value of the CDIs allotted under the Placement.




	14.	 	Placement application form & payment details






To confirm your irrevocable application for the allotment and issue of the number of Placement CDIs
and Placement Options set out in Section 2 above to you, on the terms set out in this Subscription
Agreement and your acceptance of the terms and conditions of the Placement as set out in this
Subscription Agreement, please complete, sign and return a copy of the Placement Application Form
to us by fax on or before 4.00pm (Australian Eastern Daylight Time) on Friday, 26 November 2010 to:




[insert name of Broker]



	 	 	 	 	 
	 

	 	Fax No:
	 	[insert details]
	 

	 	Attention:
	 	[insert name]






DVP




As it is the intention that settlement of your participation in the Placement will be by way of
DVP, we will require cleared funds in your account with us to enable settlement. We will discuss
this directly with you.



In the event that you decide not to settle by DVP:



Electronic funds transfers:



Electronic funds transfers must be made in Australian currency and all transfer fees and bank
charges must be deducted from the sending bank. Transfers should be directed as follows:



	 	 	 	 	 
	Account Holder:

	 	Unilife Medical Solutions Limited
	 
	Account Name:

	 	Unilife Medical Solutions Limited — Subscription Account
	 
	Bank Name:

	 	Westpac Banking Corporation
	 
	Branch:

	 	Royal Exchange
	 
	BSB (Australian transfers):

	 	032-002	 
	Account Number:

	 	398135	 
	Reference:

	 	Please ensure that the EFT contains a reference to the name of the applicant as set out on the
Application Form and the name of the placement agent.
	 






Cheque payment:




Please make cheques payable to Unilife Medical Solutions Limited — Subscription Account in
Australian currency, cross it and mark it “Not Negotiable”. Cheques must be drawn on an Australian
Bank and in Australian currency.



Please note that payment by cheque is not the preferred option for settlement of funds as there is
no certainty that the Company will have cleared funds to enable settlement by the planned date.


 


 









 






			
	Subscription Agreement for Unilife Placement
	 	Page 10





Any questions relating to settlement should be directed to Andrew Cohen on +61 2 9229 2766. Please
note that while this settlement is being undertaken via CHESS it is not covered by the National
Guarantee Fund.



Yours faithfully,




[insert name]

[insert name of Broker]




	 	 	 
	Enclosures:

	 	Placement Application Form
	 

	 	Option Agreement